Revenue: As of FY2026 Q2, the actual value is USD 615 K, beating the estimate of USD 486.5 K.

EPS: As of FY2026 Q2, the actual value is USD -0.91, beating the estimate of USD -0.97.

EBIT: As of FY2026 Q2, the actual value is USD -3.722 M.

Financial and Operational Metrics

The provided reference, a Form 8-K filing by SeaStar Medical Holding Corporation, dated August 12, 2026, explicitly states that actual financial and operational metrics, including revenue, net income, gross margin, operating profit, cash flow, or any forward-looking guidance, are not contained within the provided text of this Form 8-K.